Assignee
VIRION THERAPEUTICS LLC
US·3 granted patents·2 pending applications·4 citations·filing 2021–2025
Top patents by PatentIndex Score
5 records- 0190US12290561B2Adenoviral vectors encoding hepatitis b viral antigens fused to herpes virus glycoprotein d and methods of using the sameVIRION THERAPEUTICS LLC·Filed 2023·Granted May 6, 2025·2 cites·20 claims
- 0289US11291716B2Adenoviral vectors encoding hepatitis B viral antigens fused to herpes virus glycoprotein D and methods of using the sameVIRION THERAPEUTICS LLC·Filed 2021·Granted Apr 5, 2022·2 cites·22 claims
- 0373US11850282B2Adenoviral vectors encoding hepatitis B viral antigens fused to herpes virus glycoprotein D and methods of using the sameVIRION THERAPEUTICS LLC·Filed 2022·Granted Dec 26, 2023·0 cites·21 claims
- 0469US2025228934A1Adenoviral vectors encoding hepatitis b viral antigens fused to herpes virus glycoprotein d and methods of using the sameVIRION THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
- 0556US2024269271A1Glycoprotein d variants as vaccine adjuvantsVIRION THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VIRION THERAPEUTICS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →